Highlights

1998:
Malecare creates the world’s first Gay/Bisexual prostate cancer patient advocacy and support program.
Malecare creates the world’s first Male Breast Cancer advocacy and support program.
Malecare creates a new clinical practice called LGBT psycho-oncology.

2002:
Malecare builds awareness of the disparity of African-American men dying at twice the rate as Caucasian men from prostate cancer.
Malecare creates the world’s first African-American Prostate Cancer Research Directory.

2004:
Malecare creates the world’s first cancer survivor dating website, CancerMatch.com, highlighting unique issues that challenge single men and women diagnosed with cancer.

2005:
Malecare creates the world’s first cancer survivor advocacy organization focused on serving Lesbian, Gay, Bisexual, and Transgender people, the National LGBT Cancer Project.
Malecare creates a program to improve health and parenting skills for African American fathers, the Black Dad Connection.

2007:
Malecare becomes the world’s first organization to identify advanced stage prostate cancer patients as a cohort with unique psychosocial and treatment navigation issues.

Malecare creates the world’s first psycho-social support program to focus exclusively on men presently with advanced stage prostate cancer.

2007:
Malecare creates the world’s first psycho-social support program to focus on advanced-stage prostate cancer.

2011:
Malecare creates an international collaboration of national prostate cancer organizations, the Global Prostate Cancer Alliance. The Global Prostate Cancer Alliance can be seen at https://prostatecanceralliance.org .

2013:
Malecare creates the world’s first cancer research crowdfunding platform, Start A Cure; funding research at academic centers such as Harvard and John’s Hopkins.
Malecare develops a new model for patient advocacy, called Patient Action Leaders.

2014:
Malecare creates an African American and prostate cancer advocacy program called Twice As Many.
Malecare creates a research unit, focusing on psycho-social investigations.

2015:
Malecare invents a nuclear medicine quality assurance device and becomes one of the very few patient advocacy organizations to earn a patent.

2016:
Malecare launches Cancergraph, an iOS and Android quality of life serial data collection and distribution app. Cancergraph was favorably reviewed in The Lancet and is currently widely used in English, Italian, Spanish and Chinese language versions.

2017:
Malecare becomes an NIH funded research site. Malecare, along with our academic partner, the University of Minnesota, began an NIH/NCI funded clinical trial to investigate an intervention for restoring the quality of life for post-treatment prostate cancer patients.

2019:
Malecare produces the world’s first national prostate cancer patient conference to feature an all-female faculty.